Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Bio-Rad Laboratories (NY: BIO)
524.13 USD  -1.09 (-0.21%)
Official Closing Price  /  Updated: 6:59 PM EDT, Aug 7, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 181,400
Open 524.64
Bid (Size) 507.95 (1)
Ask (Size) 566.98 (1)
Prev. Close 525.22
Today's Range 518.62 - 527.41
52wk Range 309.38 - 540.06
Shares Outstanding 24,701,407
Dividend Yield N/A
Performance
YTD
+40.83%
+40.83%
1 Month
+12.12%
+12.12%
3 Month
+14.85%
+14.85%
6 Month
+41.54%
+41.54%
1 Year
+58.03%
+58.03%
Top News
More News
The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court’s Award of Damages
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the United States Court of Appeals for the Federal Circuit... Read More
from Business Wire News Releases
Undervalued US Stocks With Bullish Signals: $ASX $BIO $MFC
category The Market Signal
from The Market Signal
More News
Read More
Bio-Rad Reports Second-Quarter 2020 Financial Results
from Business Wire News Releases
10 Biggest Price Target Changes For Friday
category FB , CMCSA , Price Target Changes , and 13 more.
from Benzinga
Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript
category BIO/B , BIO , Market News
from Motley Fool
Earnings Season Watch List: Bio Rad Labs
from Investor's Business Daily
Top Stocks Breaking Out To New Highs Include These Coronavirus Plays
from Investor's Business Daily
The Daily Biotech Pulse: Sanofi-GSK Land $2.1M Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
category PRPO , PAND , ACHV , and 56 more.
from Benzinga
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
category FDA , GILD , BEAT , and 68 more.
from Benzinga
The Daily Biotech Pulse: Spectrum's Positive Dementia Readout, Pfizer, BioNTech Start Late-Stage Coronavirus Trial, resTORbio Receives COVID-19 Funding
category BIO , Offerings , CRSP , and 60 more.
from Benzinga
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
category IBB , Benzinga , ANIK , and 78 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.